The novel findings suggest the possibility that inhibition of Brf1 expression may be a potential approach to repress alcohol-promoted cell transformation and breast cancer development and to increase the efficacy of Tam treatment in Tam-resistant cases of ER+ breast cancer. The gene discussed is BRF1; the disease is breast cancer.